OUH - Lipid Clinic

Atherosclerosis and Lipidology

Kjetil RetterstølGroup leader — Kjetil Retterstøl
Group leader

Our research is focused on exploiting the existing knowledge about preventing atherosclerosis and cardiovascular disease both in individuals and in the society.

We include epidemiology, clinical and molecular. Focus is on fatty acids, cholesterol, familiar hypercholesterolemia and novel biomarkers for cardiovascular diseases.

Research projects

Blood lipids, dietary fatty acids and cardiovascular disease in Norway

Morbidity, mortality and the use of Medication in Familial Hypercholesterolemia. A registry study.

The Vascular lifestyle-intervention and Screening in pharmacies (VISA)-study

Community Outreach to Identify Unknown High-Risk Individuals to Prevent Premature Cardiovascular Disease (Check and Prevent- study)

Scroll to top

Recent publications

Strøm TB, Asprusten E, Laerdahl JK, Øygard I, Hussain MM, Bogsrud MP, Leren TP (2023)
Missense mutation Q384K in the APOB gene affecting the large lipid transfer module of apoB reduces the secretion of apoB-100 in the liver without reducing the secretion of apoB-48 in the intestine
J Clin Lipidol (in press)
DOI 10.1016/j.jacl.2023.08.009, PubMed 37718180

Vistisen D, Carstensen B, Elisabetta P, Lanzinger S, Tan EC, Yabe D, Kim DJ, Sheu WH, Melzer-Cohen C, Holl RW, Núñez J, Ha KH, Halvorsen S, Langslet G, Karasik A, Nyström T, Niskanen L, Guleria S, Klement R, Carrasco M, Foersch J, Shay C, Koeneman L, Hoti F, Farsani SF et al. (2023)
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia
Cardiovasc Diabetol, 22 (1), 233
DOI 10.1186/s12933-023-01963-9, PubMed 37653496

Holven KB (2023)
Plasma cholesterol levels in infancy: a neglected resource
Eur Heart J (in press)
DOI 10.1093/eurheartj/ehad558, PubMed 37632413

More publications